Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations

Breath gas analysis is a promising technology for medical applications. By identifying disease-specific biomarkers in the breath of patients, a non-invasive and easy method for early diagnosis or therapy monitoring can be developed. In order to achieve this goal, one essential prerequisite is the reproducibility of the method applied, i.e. the quantification of exhaled volatile organic compounds (VOCs). The variability of breath gas VOC measurements can be affected by many factors. In this respect, sampling-specific parameters like flow rate and volume of exhalation, exhalation with or without breath holding, exhalation in single or multiple breathing and volume of air inhaled before breath gas exhalation can play a vital role. These factors affecting the measurements must be controlled by optimizing the sampling procedure. For such an optimization, it is important to know how exactly the different parameters affect the exhaled VOC concentrations. Therefore, a study has been undertaken in order to identify some effects of different breath sampling-specific parameters on the exhaled VOC profile using the mixed expired breath sampling technique. It was found that parameters such as filling the sampling bag with high or low flow rate of exhalation, with multiple or single exhalations, in different volumes of exhalation, with breath holding and under different surrounding air conditions significantly affect the concentrations of the exhaled VOCs. Therefore, the specific results of this work should be taken into account before planning new breath gas studies or developing new breath gas collection systems in order to minimize the number of artefacts affecting the concentration of exhaled VOCs.

[1]  P. Španěl,et al.  Ambient analysis of trace compounds in gaseous media by SIFT-MS. , 2011, The Analyst.

[2]  D. Ziegler,et al.  Application of isotope-selective nondispersive infrared spectrometry (IRIS) for evaluation of [13C]octanoic acid gastric-emptying breath tests: comparison with isotope ratio-mass spectrometry (IRMS). , 1997, Clinical chemistry.

[3]  Erica R Thaler,et al.  Electronic Nose Prediction of a Clinical Pneumonia Score: Biosensors and Microbes , 2005, Anesthesiology.

[4]  Jörg Ingo Baumbach,et al.  ION MOBILITY SPECTROMETRY: A NEW METHOD FOR THE DETECTION OF LUNG CANCER AND AIRWAY INFECTION IN EXHALED AIR? FIRST RESULTS OF A PILOT STUDY , 2005 .

[5]  I. Horváth,et al.  Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. , 1998, American journal of respiratory and critical care medicine.

[6]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[7]  Kevin Gleeson,et al.  Detection of lung cancer with volatile markers in the breath. , 2003, Chest.

[8]  M. Griese,et al.  Elemental and ion composition of exhaled air condensate in cystic fibrosis. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  K. Schwarz,et al.  Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS , 2009, Journal of breath research.

[10]  C. Hoeschen,et al.  Investigations on the variability of breath gas sampling using PTR-MS , 2009, Journal of breath research.

[11]  H. J. O’neill,et al.  A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.

[12]  M. Phillips,et al.  Breath markers of oxidative stress in patients with unstable angina. , 2003, Heart disease.

[13]  Simona M Cristescu,et al.  The suitability of Tedlar bags for breath sampling in medical diagnostic research , 2007, Physiological measurement.

[14]  M. Phillips,et al.  Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.

[15]  Josef Guttmann,et al.  CO2-controlled sampling of alveolar gas in mechanically ventilated patients , 2001 .

[16]  J W Dallinga,et al.  A profile of volatile organic compounds in breath discriminates COPD patients from controls. , 2009, Respiratory medicine.

[17]  P. Jackson,et al.  Medical Statistics — a common sense approach , 2001 .

[18]  Tianshu Wang,et al.  Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity , 2008, Journal of breath research.

[19]  P. Barnes,et al.  Elevation of exhaled ethane concentration in asthma. , 2000, American journal of respiratory and critical care medicine.

[20]  Patrik Španěl,et al.  Direct, rapid quantitative analyses of BVOCs using SIFT-MS and PTR-MS obviating sample collection , 2011 .

[21]  D. Klemp,et al.  Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis , 2006, European Respiratory Journal.

[22]  David Smith,et al.  Progress in SIFT-MS: breath analysis and other applications. , 2011, Mass spectrometry reviews.

[23]  P. Crutzen,et al.  Comprehensive laboratory measurements of biomass‐burning emissions: 2. First intercomparison of open‐path FTIR, PTR‐MS, and GC‐MS/FID/ECD , 2004 .

[24]  Tianshu Wang,et al.  Generation of volatile compounds on mouth exposure to urea and sucrose: implications for exhaled breath analysis , 2006, Physiological measurement.

[25]  Julian King,et al.  Physiological modeling of isoprene dynamics in exhaled breath. , 2010, Journal of theoretical biology.

[26]  C. Deng,et al.  Development of gas chromatography–mass spectrometry following headspace single-drop microextraction and simultaneous derivatization for fast determination of the diabetes biomarker, acetone in human blood samples , 2006 .

[27]  A. Hansel,et al.  Methanol measurements in the lower troposphere near Innsbruck (047°16′N; 011°24′E), Austria , 2001 .

[28]  Jens Herbig,et al.  Buffered end-tidal (BET) sampling—a novel method for real-time breath-gas analysis , 2008, Journal of breath research.

[29]  G. Bartosz,et al.  Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia. , 2004, Respiratory medicine.

[30]  L. T. McGrath,et al.  Breath isoprene during acute respiratory exacerbation in cystic fibrosis. , 2000, The European respiratory journal.

[31]  L. Hoffman,et al.  Markers of Lung Disease in Exhaled Breath: Nitric Oxide , 2006, Biological Research for Nursing.

[32]  M. O’Hara,et al.  Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry , 2008, Physiological measurement.

[33]  Olaf Tietje,et al.  Prediction of breast cancer using volatile biomarkers in the breath , 2006, Breast Cancer Research and Treatment.

[34]  S. George,et al.  Dynamics of soluble gas exchange in the airways. III. Single-exhalation breathing maneuver. , 1993, Journal of applied physiology.

[35]  Konrad Schwarz,et al.  Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS , 2008, Journal of breath research.

[36]  A. Wisthaler,et al.  Proton-transfer-reaction mass spectrometry (PTR-MS): on-line monitoring of volatile organic compounds at volume mixing ratios of a few pptv , 1999 .

[37]  David Smith,et al.  Dispersal kinetics of deuterated water in the lungs and airways following mouth inhalation: real-time breath analysis by flowing afterglow mass spectrometry (FA-MS) , 2010, Journal of breath research.

[38]  Olaf Tietje,et al.  Volatile biomarkers of pulmonary tuberculosis in the breath. , 2007, Tuberculosis.

[39]  K. Torén,et al.  Determination of ethane, pentane and isoprene in exhaled air – effects of breath‐holding, flow rate and purified air , 2007, Acta physiologica.

[40]  D. Blake,et al.  Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[41]  Werner Lindinger,et al.  Proton transfer reaction mass spectrometry: on-line trace gas analysis at the ppb level , 1995 .

[42]  N. Siafakas,et al.  Biomarkers in COPD. , 2007, Current medicinal chemistry.

[43]  Sabine Kischkel,et al.  Impact of sampling procedures on the results of breath analysis , 2008, Journal of breath research.

[44]  A. Jones Quantitative measurements of the alcohol concentration and the temperature of breath during a prolonged exhalation. , 1982, Acta physiologica Scandinavica.

[45]  M. Hlastala,et al.  The Impact of Breathing Pattern and Lung Size on the Alcohol Breath Test , 2007, Annals of Biomedical Engineering.

[46]  G. Wimmer,et al.  Model Based Determination of Detection Limits for Proton Transfer Reaction Mass Spectrometer , 2010 .

[47]  H. Haick,et al.  Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. , 2008, Nano letters.

[48]  M. Hlastala,et al.  Measuring airway exchange of endogenous acetone using a single-exhalation breathing maneuver. , 2006, Journal of applied physiology.

[49]  E. Wouters,et al.  Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[50]  Julian King,et al.  A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone , 2010, Journal of mathematical biology.

[51]  M P Hlastala,et al.  The alcohol breath test--a review. , 1998, Journal of applied physiology.

[52]  J. Beauchamp,et al.  On the use of Tedlar® bags for breath-gas sampling and analysis , 2008, Journal of breath research.

[53]  E. Eger,et al.  Is the End‐tidal Anesthetic Partial Pressure an Accurate Measure of the Arterial Anesthetic Partial Pressure? , 1971, Anesthesiology.

[54]  M. Phillips,et al.  Increased breath biomarkers of oxidative stress in diabetes mellitus. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[55]  X. Zhang,et al.  Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[56]  C. Hoeschen,et al.  Effects of carbon dioxide in breath gas on proton transfer reaction-mass spectrometry (PTR-MS) measurements , 2008 .

[57]  T. Pietras,et al.  Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. , 1999, Respiratory medicine.

[58]  H. J. O’neill,et al.  Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.

[59]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[60]  C. Mayhew,et al.  Real-time breath monitoring of propofol and its volatile metabolites during surgery using a novel mass spectrometric technique: a feasibility study. , 2003, British journal of anaesthesia.

[61]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[62]  P. Španěl,et al.  The quantification of carbon dioxide in humid air and exhaled breath by selected ion flow tube mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[63]  A. Aceto,et al.  Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[64]  Anton Amann,et al.  Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .

[65]  P. Španěl,et al.  Volatile metabolites in the exhaled breath of healthy volunteers: their levels and distributions , 2007, Journal of breath research.

[66]  M. Mcculloch,et al.  Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers , 2006, Integrative cancer therapies.

[67]  M J Padgett,et al.  Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer. , 2006, Respiratory medicine.

[68]  Albert L. Babb,et al.  Modeling Soluble Gas Exchange in the Airways and Alveoli , 2003, Annals of Biomedical Engineering.

[69]  A. Lagg,et al.  Methanol in human breath. , 1995, Alcoholism, clinical and experimental research.

[70]  L. T. Tanoue Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath , 2007 .

[71]  N. Siafakas,et al.  Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. , 2002, Chest.

[72]  P. Barnes,et al.  Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. , 2001, Chest.

[73]  C. N. Hewitt,et al.  Performance characteristics and applications of a proton transfer reaction-mass spectrometer for measuring volatile organic compounds in ambient air. , 2002, Environmental science & technology.

[74]  A. Hansel,et al.  Endogenous production of methanol after the consumption of fruit. , 1997, Alcoholism, clinical and experimental research.

[75]  P. Monks,et al.  Proton-transfer reaction mass spectrometry. , 2009, Chemical reviews.

[76]  S. George,et al.  Modeling the concentration of ethanol in the exhaled breath following pretest breathing maneuvers , 2006, Annals of Biomedical Engineering.

[77]  K. Aben,et al.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.